世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ビノレルビン酒石酸塩APIの世界市場インサイト、2029年までの予測


Global Vinorelbine Tartrate API Market Insights, Forecast to 2029

世界のビノレルビン酒石酸塩API市場は、COVID-19とロシア・ウクライナ戦争の二重の影響を受けた2022年の3億2,270万米ドルに比べ、2023年には3億4,900万米ドルに達すると予想され、%のプラス成長が見込まれている... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2023年8月9日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

世界のビノレルビン酒石酸塩API市場は、COVID-19とロシア・ウクライナ戦争の二重の影響を受けた2022年の3億2,270万米ドルに比べ、2023年には3億4,900万米ドルに達すると予想され、%のプラス成長が見込まれている。川下産業からの需要増加を背景に、ビノレルビン酒石酸塩API産業は2029年に4億7690万米ドルに達すると評価されている。2023年から2029年までのCAGRは5.3%である。
酒石酸ビノレルビン原薬の世界5大メーカーは、ピエール・ファーブル、湖北宏源医薬技術、漢創薬業集団、ミナケム、斉魯薬業で、88%以上を占めている。その中でピエール・ファーブルが市場シェア約51%でトップである。最大の市場はヨーロッパで、シェアは約42%、次いで北米が約16%、中国が約15%となっている。製品の種類別では、純度99%以上のものが市場全体の約95%を占め、最大のシェアを占めている。また、製品の用途別では、最大の用途はビノレルビンカプセルであり、次いでビノレルビン注射剤である。

レポートの対象
本レポートは、2018年から2029年までの世界のビノレルビン酒石酸塩API市場の概観を紹介し、読者が世界のビノレルビン酒石酸塩API市場を多角的に包括的に理解することを目的としています。2018年から2029年までの地域の生産量、販売量、収益、2018年から2023年までのメーカーの生産能力、販売量、価格、収益、粗利益率などの項目が分析されています。さらに、2018年から2029年までの各地域における製品タイプおよび用途の売上高および収益も取り上げています。

レポートに掲載されたメーカー、タイプ、アプリケーション、地域
企業別
ピエール・ファーブル
湖北宏源医薬科技
ハンソー製薬グループ
ミナケム
斉魯薬業
広州パーソン製薬
広州漢方製薬
タイプ別セグメント
純度99
純度<99
用途別セグメント
ビノレルビンカプセル
ビノレルビン注射剤
地域別生産量
北米
欧州
中国
日本
地域別売上高
米国およびカナダ
米国
カナダ
中国
アジア(中国を除く)
日本
韓国
中国 台湾
東南アジア
インド
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
ラテンアメリカ、中東、アフリカ
ブラジル
メキシコ
トルコ
イスラエル
GCC諸国

章の概要
第1章:製品の定義、タイプ、用途の紹介
第2章 2018年から2029年までの地域別生産量分析
第3章:2018年から2029年までの地域別収益および販売量分析
第4章:メーカーの売上高、収益および価格分析、メーカーのビノレルビン酒石酸塩API工場分布、ビノレルビン酒石酸塩APIの商業日、提供される製品タイプ、M&Aおよび拡大活動を含む。
第5章:2018年から2029年までの世界のタイプ別製品売上高、収益、価格分析
第6章:2018年から2029年までの世界的な用途別製品売上高、収益および価格分析
第7章:米国・カナダにおける2018年から2029年までのタイプ別・用途別製品売上高、収益分析2018年から2029年までの米国&カナダにおける各国別製品売上高、収益分析
第8章:ヨーロッパにおける2018年から2029年までの製品売上高、タイプ別および用途別収益分析。2018年から2029年までの欧州各国の製品売上高、収益分析
第9章:中国における2018年から2029年までの製品売上高、タイプ別および用途別収益分析。2018年から2029年までの中国の製品売上高、収益分析
第10章:2018年から2029年までのアジア(中国を除く)における製品売上高、タイプ別および用途別収益分析。2018年から2029年までのアジア(中国を除く)各国の製品売上高、収益分析
第11章:2018年から2029年までの中東、アフリカ、ラテンアメリカにおける製品の販売、タイプ別および用途別の収益分析。2018年から2029年までの中東、アフリカ、ラテンアメリカの各国における製品売上高、収益分析。
第12章:メーカーの概要、企業の基本情報、主要事業、ビノレルビン酒石酸塩APIの紹介などをカバーする。2018年から2023年までの各社のビノレルビン酒石酸塩API生産能力、売上高、収益、価格およびグロスマージン
第13章:原材料、製造コストのような産業チェーン分析。市場チャネル、流通業者、顧客分析
第14章:市場機会と課題分析
第15章:酒石酸ビノレルビン原薬に関するQYResearchの結論
第16章:QYResearchが採用した方法論とデータソース


ページTOPに戻る


目次

1 Study Coverage
1.1 Vinorelbine Tartrate API Product Introduction
1.2 Market by Type
1.2.1 Global Vinorelbine Tartrate API Market Size by Type, 2018 VS 2022 VS 2029
1.2.2 Purity≥99%
1.2.3 Purity<99%
1.3 Market by Application
1.3.1 Global Vinorelbine Tartrate API Market Size by Application, 2018 VS 2022 VS 2029
1.3.2 Vinorelbine Capsules
1.3.3 Vinorelbine Injection
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Vinorelbine Tartrate API Production
2.1 Global Vinorelbine Tartrate API Production Capacity (2018-2029)
2.2 Global Vinorelbine Tartrate API Production by Region: 2018 VS 2022 VS 2029
2.3 Global Vinorelbine Tartrate API Production by Region
2.3.1 Global Vinorelbine Tartrate API Historic Production by Region (2018-2023)
2.3.2 Global Vinorelbine Tartrate API Forecasted Production by Region (2024-2029)
2.3.3 Global Vinorelbine Tartrate API Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Vinorelbine Tartrate API Revenue Estimates and Forecasts 2018-2029
3.2 Global Vinorelbine Tartrate API Revenue by Region
3.2.1 Global Vinorelbine Tartrate API Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global Vinorelbine Tartrate API Revenue by Region (2018-2023)
3.2.3 Global Vinorelbine Tartrate API Revenue by Region (2024-2029)
3.2.4 Global Vinorelbine Tartrate API Revenue Market Share by Region (2018-2029)
3.3 Global Vinorelbine Tartrate API Sales Estimates and Forecasts 2018-2029
3.4 Global Vinorelbine Tartrate API Sales by Region
3.4.1 Global Vinorelbine Tartrate API Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global Vinorelbine Tartrate API Sales by Region (2018-2023)
3.4.3 Global Vinorelbine Tartrate API Sales by Region (2024-2029)
3.4.4 Global Vinorelbine Tartrate API Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Vinorelbine Tartrate API Sales by Manufacturers
4.1.1 Global Vinorelbine Tartrate API Sales by Manufacturers (2018-2023)
4.1.2 Global Vinorelbine Tartrate API Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vinorelbine Tartrate API in 2022
4.2 Global Vinorelbine Tartrate API Revenue by Manufacturers
4.2.1 Global Vinorelbine Tartrate API Revenue by Manufacturers (2018-2023)
4.2.2 Global Vinorelbine Tartrate API Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Vinorelbine Tartrate API Revenue in 2022
4.3 Global Vinorelbine Tartrate API Sales Price by Manufacturers
4.4 Global Key Players of Vinorelbine Tartrate API, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Vinorelbine Tartrate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Vinorelbine Tartrate API, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Vinorelbine Tartrate API, Product Offered and Application
4.8 Global Key Manufacturers of Vinorelbine Tartrate API, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Vinorelbine Tartrate API Sales by Type
5.1.1 Global Vinorelbine Tartrate API Historical Sales by Type (2018-2023)
5.1.2 Global Vinorelbine Tartrate API Forecasted Sales by Type (2024-2029)
5.1.3 Global Vinorelbine Tartrate API Sales Market Share by Type (2018-2029)
5.2 Global Vinorelbine Tartrate API Revenue by Type
5.2.1 Global Vinorelbine Tartrate API Historical Revenue by Type (2018-2023)
5.2.2 Global Vinorelbine Tartrate API Forecasted Revenue by Type (2024-2029)
5.2.3 Global Vinorelbine Tartrate API Revenue Market Share by Type (2018-2029)
5.3 Global Vinorelbine Tartrate API Price by Type
5.3.1 Global Vinorelbine Tartrate API Price by Type (2018-2023)
5.3.2 Global Vinorelbine Tartrate API Price Forecast by Type (2024-2029)
6 Market Size by Application
6.1 Global Vinorelbine Tartrate API Sales by Application
6.1.1 Global Vinorelbine Tartrate API Historical Sales by Application (2018-2023)
6.1.2 Global Vinorelbine Tartrate API Forecasted Sales by Application (2024-2029)
6.1.3 Global Vinorelbine Tartrate API Sales Market Share by Application (2018-2029)
6.2 Global Vinorelbine Tartrate API Revenue by Application
6.2.1 Global Vinorelbine Tartrate API Historical Revenue by Application (2018-2023)
6.2.2 Global Vinorelbine Tartrate API Forecasted Revenue by Application (2024-2029)
6.2.3 Global Vinorelbine Tartrate API Revenue Market Share by Application (2018-2029)
6.3 Global Vinorelbine Tartrate API Price by Application
6.3.1 Global Vinorelbine Tartrate API Price by Application (2018-2023)
6.3.2 Global Vinorelbine Tartrate API Price Forecast by Application (2024-2029)
7 US & Canada
7.1 US & Canada Vinorelbine Tartrate API Market Size by Type
7.1.1 US & Canada Vinorelbine Tartrate API Sales by Type (2018-2029)
7.1.2 US & Canada Vinorelbine Tartrate API Revenue by Type (2018-2029)
7.2 US & Canada Vinorelbine Tartrate API Market Size by Application
7.2.1 US & Canada Vinorelbine Tartrate API Sales by Application (2018-2029)
7.2.2 US & Canada Vinorelbine Tartrate API Revenue by Application (2018-2029)
7.3 US & Canada Vinorelbine Tartrate API Sales by Country
7.3.1 US & Canada Vinorelbine Tartrate API Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada Vinorelbine Tartrate API Sales by Country (2018-2029)
7.3.3 US & Canada Vinorelbine Tartrate API Revenue by Country (2018-2029)
7.3.4 United States
7.3.5 Canada
8 Europe
8.1 Europe Vinorelbine Tartrate API Market Size by Type
8.1.1 Europe Vinorelbine Tartrate API Sales by Type (2018-2029)
8.1.2 Europe Vinorelbine Tartrate API Revenue by Type (2018-2029)
8.2 Europe Vinorelbine Tartrate API Market Size by Application
8.2.1 Europe Vinorelbine Tartrate API Sales by Application (2018-2029)
8.2.2 Europe Vinorelbine Tartrate API Revenue by Application (2018-2029)
8.3 Europe Vinorelbine Tartrate API Sales by Country
8.3.1 Europe Vinorelbine Tartrate API Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe Vinorelbine Tartrate API Sales by Country (2018-2029)
8.3.3 Europe Vinorelbine Tartrate API Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Vinorelbine Tartrate API Market Size by Type
9.1.1 China Vinorelbine Tartrate API Sales by Type (2018-2029)
9.1.2 China Vinorelbine Tartrate API Revenue by Type (2018-2029)
9.2 China Vinorelbine Tartrate API Market Size by Application
9.2.1 China Vinorelbine Tartrate API Sales by Application (2018-2029)
9.2.2 China Vinorelbine Tartrate API Revenue by Application (2018-2029)
10 Asia (excluding China)
10.1 Asia Vinorelbine Tartrate API Market Size by Type
10.1.1 Asia Vinorelbine Tartrate API Sales by Type (2018-2029)
10.1.2 Asia Vinorelbine Tartrate API Revenue by Type (2018-2029)
10.2 Asia Vinorelbine Tartrate API Market Size by Application
10.2.1 Asia Vinorelbine Tartrate API Sales by Application (2018-2029)
10.2.2 Asia Vinorelbine Tartrate API Revenue by Application (2018-2029)
10.3 Asia Vinorelbine Tartrate API Sales by Region
10.3.1 Asia Vinorelbine Tartrate API Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia Vinorelbine Tartrate API Revenue by Region (2018-2029)
10.3.3 Asia Vinorelbine Tartrate API Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Vinorelbine Tartrate API Market Size by Type
11.1.1 Middle East, Africa and Latin America Vinorelbine Tartrate API Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America Vinorelbine Tartrate API Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America Vinorelbine Tartrate API Market Size by Application
11.2.1 Middle East, Africa and Latin America Vinorelbine Tartrate API Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America Vinorelbine Tartrate API Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America Vinorelbine Tartrate API Sales by Country
11.3.1 Middle East, Africa and Latin America Vinorelbine Tartrate API Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America Vinorelbine Tartrate API Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America Vinorelbine Tartrate API Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 Pierre Fabre
12.1.1 Pierre Fabre Company Information
12.1.2 Pierre Fabre Overview
12.1.3 Pierre Fabre Vinorelbine Tartrate API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 Pierre Fabre Vinorelbine Tartrate API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Pierre Fabre Recent Developments
12.2 Hubei Hongyuan Pharmaceutical Technology
12.2.1 Hubei Hongyuan Pharmaceutical Technology Company Information
12.2.2 Hubei Hongyuan Pharmaceutical Technology Overview
12.2.3 Hubei Hongyuan Pharmaceutical Technology Vinorelbine Tartrate API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 Hubei Hongyuan Pharmaceutical Technology Vinorelbine Tartrate API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Hubei Hongyuan Pharmaceutical Technology Recent Developments
12.3 Hansoh Pharmaceuticak Group
12.3.1 Hansoh Pharmaceuticak Group Company Information
12.3.2 Hansoh Pharmaceuticak Group Overview
12.3.3 Hansoh Pharmaceuticak Group Vinorelbine Tartrate API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 Hansoh Pharmaceuticak Group Vinorelbine Tartrate API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Hansoh Pharmaceuticak Group Recent Developments
12.4 Minakem
12.4.1 Minakem Company Information
12.4.2 Minakem Overview
12.4.3 Minakem Vinorelbine Tartrate API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Minakem Vinorelbine Tartrate API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Minakem Recent Developments
12.5 Qilu Pharmaceutical
12.5.1 Qilu Pharmaceutical Company Information
12.5.2 Qilu Pharmaceutical Overview
12.5.3 Qilu Pharmaceutical Vinorelbine Tartrate API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 Qilu Pharmaceutical Vinorelbine Tartrate API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Qilu Pharmaceutical Recent Developments
12.6 Guangzhou Person Pharmaceutical
12.6.1 Guangzhou Person Pharmaceutical Company Information
12.6.2 Guangzhou Person Pharmaceutical Overview
12.6.3 Guangzhou Person Pharmaceutical Vinorelbine Tartrate API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 Guangzhou Person Pharmaceutical Vinorelbine Tartrate API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Guangzhou Person Pharmaceutical Recent Developments
12.7 Guangzhou Hanfang Pharmaceutical
12.7.1 Guangzhou Hanfang Pharmaceutical Company Information
12.7.2 Guangzhou Hanfang Pharmaceutical Overview
12.7.3 Guangzhou Hanfang Pharmaceutical Vinorelbine Tartrate API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.7.4 Guangzhou Hanfang Pharmaceutical Vinorelbine Tartrate API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Guangzhou Hanfang Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Vinorelbine Tartrate API Industry Chain Analysis
13.2 Vinorelbine Tartrate API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Vinorelbine Tartrate API Production Mode & Process
13.4 Vinorelbine Tartrate API Sales and Marketing
13.4.1 Vinorelbine Tartrate API Sales Channels
13.4.2 Vinorelbine Tartrate API Distributors
13.5 Vinorelbine Tartrate API Customers
14 Vinorelbine Tartrate API Market Dynamics
14.1 Vinorelbine Tartrate API Industry Trends
14.2 Vinorelbine Tartrate API Market Drivers
14.3 Vinorelbine Tartrate API Market Challenges
14.4 Vinorelbine Tartrate API Market Restraints
15 Key Finding in The Global Vinorelbine Tartrate API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

 

ページTOPに戻る


 

Summary

Global Vinorelbine Tartrate API market is expected to reach to US$ 349 million in 2023, with a positive growth of %, compared with US$ 322.7 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Vinorelbine Tartrate API industry is evaluated to reach US$ 476.9 million in 2029. The CAGR will be 5.3% during 2023 to 2029.
Global 5 largest manufacturers of Vinorelbine Tartrate API are Pierre Fabre, Hubei Hongyuan Pharmaceutical Technology, Hansoh Pharmaceuticak Group, Minakem and Qilu Pharmaceutical, which make up over 88%. Among them, Pierre Fabre is the leader with about 51% market share. Europe is the largest market, with a share about 42%, followed by North America and China, with the share about 16% and 15%. In terms of product type, Purity≥99% occupy the largest share of the total market, about 95%. And in terms of product Application, the largest application is Vinorelbine Capsules, followed by Vinorelbine Injection.

Report Covers:
This report presents an overview of global Vinorelbine Tartrate API market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Vinorelbine Tartrate API market with multiple angles. Items like regional production, sales, revenue from 2018 to 2029 and manufacturers’ capacity, sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Pierre Fabre
Hubei Hongyuan Pharmaceutical Technology
Hansoh Pharmaceuticak Group
Minakem
Qilu Pharmaceutical
Guangzhou Person Pharmaceutical
Guangzhou Hanfang Pharmaceutical
Segment by Type
Purity≥99%
Purity<99%
Segment by Application
Vinorelbine Capsules
Vinorelbine Injection
Production by Region
North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Product definition, type and application introduction
Chapter 2: Regional production volume analysis from 2018 to 2029
Chapter 3: Regional revenue and sales volume analysis from 2018 to 2029
Chapter 4: Manufacturers’ sales, revenue and price analysis, including manufacturers’ Vinorelbine Tartrate API plant distribution, commercial date of Vinorelbine Tartrate API, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 5: Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 6: Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 7: Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 8: Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 9: Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 10: Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 11: Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 12: Manufacturers’ outline, covering company’s basic information, major business, Vinorelbine Tartrate API introduction, etc. Vinorelbine Tartrate API Capacity, Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 13: Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 14: Market opportunities and challenges analysis
Chapter 15: QYResearch’s Conclusions of Vinorelbine Tartrate API
Chapter 16: Methodology and Data Sources adopted by QYResearch



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Vinorelbine Tartrate API Product Introduction
1.2 Market by Type
1.2.1 Global Vinorelbine Tartrate API Market Size by Type, 2018 VS 2022 VS 2029
1.2.2 Purity≥99%
1.2.3 Purity<99%
1.3 Market by Application
1.3.1 Global Vinorelbine Tartrate API Market Size by Application, 2018 VS 2022 VS 2029
1.3.2 Vinorelbine Capsules
1.3.3 Vinorelbine Injection
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Vinorelbine Tartrate API Production
2.1 Global Vinorelbine Tartrate API Production Capacity (2018-2029)
2.2 Global Vinorelbine Tartrate API Production by Region: 2018 VS 2022 VS 2029
2.3 Global Vinorelbine Tartrate API Production by Region
2.3.1 Global Vinorelbine Tartrate API Historic Production by Region (2018-2023)
2.3.2 Global Vinorelbine Tartrate API Forecasted Production by Region (2024-2029)
2.3.3 Global Vinorelbine Tartrate API Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Vinorelbine Tartrate API Revenue Estimates and Forecasts 2018-2029
3.2 Global Vinorelbine Tartrate API Revenue by Region
3.2.1 Global Vinorelbine Tartrate API Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global Vinorelbine Tartrate API Revenue by Region (2018-2023)
3.2.3 Global Vinorelbine Tartrate API Revenue by Region (2024-2029)
3.2.4 Global Vinorelbine Tartrate API Revenue Market Share by Region (2018-2029)
3.3 Global Vinorelbine Tartrate API Sales Estimates and Forecasts 2018-2029
3.4 Global Vinorelbine Tartrate API Sales by Region
3.4.1 Global Vinorelbine Tartrate API Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global Vinorelbine Tartrate API Sales by Region (2018-2023)
3.4.3 Global Vinorelbine Tartrate API Sales by Region (2024-2029)
3.4.4 Global Vinorelbine Tartrate API Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Vinorelbine Tartrate API Sales by Manufacturers
4.1.1 Global Vinorelbine Tartrate API Sales by Manufacturers (2018-2023)
4.1.2 Global Vinorelbine Tartrate API Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vinorelbine Tartrate API in 2022
4.2 Global Vinorelbine Tartrate API Revenue by Manufacturers
4.2.1 Global Vinorelbine Tartrate API Revenue by Manufacturers (2018-2023)
4.2.2 Global Vinorelbine Tartrate API Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Vinorelbine Tartrate API Revenue in 2022
4.3 Global Vinorelbine Tartrate API Sales Price by Manufacturers
4.4 Global Key Players of Vinorelbine Tartrate API, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Vinorelbine Tartrate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Vinorelbine Tartrate API, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Vinorelbine Tartrate API, Product Offered and Application
4.8 Global Key Manufacturers of Vinorelbine Tartrate API, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Vinorelbine Tartrate API Sales by Type
5.1.1 Global Vinorelbine Tartrate API Historical Sales by Type (2018-2023)
5.1.2 Global Vinorelbine Tartrate API Forecasted Sales by Type (2024-2029)
5.1.3 Global Vinorelbine Tartrate API Sales Market Share by Type (2018-2029)
5.2 Global Vinorelbine Tartrate API Revenue by Type
5.2.1 Global Vinorelbine Tartrate API Historical Revenue by Type (2018-2023)
5.2.2 Global Vinorelbine Tartrate API Forecasted Revenue by Type (2024-2029)
5.2.3 Global Vinorelbine Tartrate API Revenue Market Share by Type (2018-2029)
5.3 Global Vinorelbine Tartrate API Price by Type
5.3.1 Global Vinorelbine Tartrate API Price by Type (2018-2023)
5.3.2 Global Vinorelbine Tartrate API Price Forecast by Type (2024-2029)
6 Market Size by Application
6.1 Global Vinorelbine Tartrate API Sales by Application
6.1.1 Global Vinorelbine Tartrate API Historical Sales by Application (2018-2023)
6.1.2 Global Vinorelbine Tartrate API Forecasted Sales by Application (2024-2029)
6.1.3 Global Vinorelbine Tartrate API Sales Market Share by Application (2018-2029)
6.2 Global Vinorelbine Tartrate API Revenue by Application
6.2.1 Global Vinorelbine Tartrate API Historical Revenue by Application (2018-2023)
6.2.2 Global Vinorelbine Tartrate API Forecasted Revenue by Application (2024-2029)
6.2.3 Global Vinorelbine Tartrate API Revenue Market Share by Application (2018-2029)
6.3 Global Vinorelbine Tartrate API Price by Application
6.3.1 Global Vinorelbine Tartrate API Price by Application (2018-2023)
6.3.2 Global Vinorelbine Tartrate API Price Forecast by Application (2024-2029)
7 US & Canada
7.1 US & Canada Vinorelbine Tartrate API Market Size by Type
7.1.1 US & Canada Vinorelbine Tartrate API Sales by Type (2018-2029)
7.1.2 US & Canada Vinorelbine Tartrate API Revenue by Type (2018-2029)
7.2 US & Canada Vinorelbine Tartrate API Market Size by Application
7.2.1 US & Canada Vinorelbine Tartrate API Sales by Application (2018-2029)
7.2.2 US & Canada Vinorelbine Tartrate API Revenue by Application (2018-2029)
7.3 US & Canada Vinorelbine Tartrate API Sales by Country
7.3.1 US & Canada Vinorelbine Tartrate API Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada Vinorelbine Tartrate API Sales by Country (2018-2029)
7.3.3 US & Canada Vinorelbine Tartrate API Revenue by Country (2018-2029)
7.3.4 United States
7.3.5 Canada
8 Europe
8.1 Europe Vinorelbine Tartrate API Market Size by Type
8.1.1 Europe Vinorelbine Tartrate API Sales by Type (2018-2029)
8.1.2 Europe Vinorelbine Tartrate API Revenue by Type (2018-2029)
8.2 Europe Vinorelbine Tartrate API Market Size by Application
8.2.1 Europe Vinorelbine Tartrate API Sales by Application (2018-2029)
8.2.2 Europe Vinorelbine Tartrate API Revenue by Application (2018-2029)
8.3 Europe Vinorelbine Tartrate API Sales by Country
8.3.1 Europe Vinorelbine Tartrate API Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe Vinorelbine Tartrate API Sales by Country (2018-2029)
8.3.3 Europe Vinorelbine Tartrate API Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Vinorelbine Tartrate API Market Size by Type
9.1.1 China Vinorelbine Tartrate API Sales by Type (2018-2029)
9.1.2 China Vinorelbine Tartrate API Revenue by Type (2018-2029)
9.2 China Vinorelbine Tartrate API Market Size by Application
9.2.1 China Vinorelbine Tartrate API Sales by Application (2018-2029)
9.2.2 China Vinorelbine Tartrate API Revenue by Application (2018-2029)
10 Asia (excluding China)
10.1 Asia Vinorelbine Tartrate API Market Size by Type
10.1.1 Asia Vinorelbine Tartrate API Sales by Type (2018-2029)
10.1.2 Asia Vinorelbine Tartrate API Revenue by Type (2018-2029)
10.2 Asia Vinorelbine Tartrate API Market Size by Application
10.2.1 Asia Vinorelbine Tartrate API Sales by Application (2018-2029)
10.2.2 Asia Vinorelbine Tartrate API Revenue by Application (2018-2029)
10.3 Asia Vinorelbine Tartrate API Sales by Region
10.3.1 Asia Vinorelbine Tartrate API Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia Vinorelbine Tartrate API Revenue by Region (2018-2029)
10.3.3 Asia Vinorelbine Tartrate API Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Vinorelbine Tartrate API Market Size by Type
11.1.1 Middle East, Africa and Latin America Vinorelbine Tartrate API Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America Vinorelbine Tartrate API Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America Vinorelbine Tartrate API Market Size by Application
11.2.1 Middle East, Africa and Latin America Vinorelbine Tartrate API Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America Vinorelbine Tartrate API Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America Vinorelbine Tartrate API Sales by Country
11.3.1 Middle East, Africa and Latin America Vinorelbine Tartrate API Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America Vinorelbine Tartrate API Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America Vinorelbine Tartrate API Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 Pierre Fabre
12.1.1 Pierre Fabre Company Information
12.1.2 Pierre Fabre Overview
12.1.3 Pierre Fabre Vinorelbine Tartrate API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 Pierre Fabre Vinorelbine Tartrate API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Pierre Fabre Recent Developments
12.2 Hubei Hongyuan Pharmaceutical Technology
12.2.1 Hubei Hongyuan Pharmaceutical Technology Company Information
12.2.2 Hubei Hongyuan Pharmaceutical Technology Overview
12.2.3 Hubei Hongyuan Pharmaceutical Technology Vinorelbine Tartrate API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 Hubei Hongyuan Pharmaceutical Technology Vinorelbine Tartrate API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Hubei Hongyuan Pharmaceutical Technology Recent Developments
12.3 Hansoh Pharmaceuticak Group
12.3.1 Hansoh Pharmaceuticak Group Company Information
12.3.2 Hansoh Pharmaceuticak Group Overview
12.3.3 Hansoh Pharmaceuticak Group Vinorelbine Tartrate API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 Hansoh Pharmaceuticak Group Vinorelbine Tartrate API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Hansoh Pharmaceuticak Group Recent Developments
12.4 Minakem
12.4.1 Minakem Company Information
12.4.2 Minakem Overview
12.4.3 Minakem Vinorelbine Tartrate API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Minakem Vinorelbine Tartrate API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Minakem Recent Developments
12.5 Qilu Pharmaceutical
12.5.1 Qilu Pharmaceutical Company Information
12.5.2 Qilu Pharmaceutical Overview
12.5.3 Qilu Pharmaceutical Vinorelbine Tartrate API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 Qilu Pharmaceutical Vinorelbine Tartrate API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Qilu Pharmaceutical Recent Developments
12.6 Guangzhou Person Pharmaceutical
12.6.1 Guangzhou Person Pharmaceutical Company Information
12.6.2 Guangzhou Person Pharmaceutical Overview
12.6.3 Guangzhou Person Pharmaceutical Vinorelbine Tartrate API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 Guangzhou Person Pharmaceutical Vinorelbine Tartrate API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Guangzhou Person Pharmaceutical Recent Developments
12.7 Guangzhou Hanfang Pharmaceutical
12.7.1 Guangzhou Hanfang Pharmaceutical Company Information
12.7.2 Guangzhou Hanfang Pharmaceutical Overview
12.7.3 Guangzhou Hanfang Pharmaceutical Vinorelbine Tartrate API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.7.4 Guangzhou Hanfang Pharmaceutical Vinorelbine Tartrate API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Guangzhou Hanfang Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Vinorelbine Tartrate API Industry Chain Analysis
13.2 Vinorelbine Tartrate API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Vinorelbine Tartrate API Production Mode & Process
13.4 Vinorelbine Tartrate API Sales and Marketing
13.4.1 Vinorelbine Tartrate API Sales Channels
13.4.2 Vinorelbine Tartrate API Distributors
13.5 Vinorelbine Tartrate API Customers
14 Vinorelbine Tartrate API Market Dynamics
14.1 Vinorelbine Tartrate API Industry Trends
14.2 Vinorelbine Tartrate API Market Drivers
14.3 Vinorelbine Tartrate API Market Challenges
14.4 Vinorelbine Tartrate API Market Restraints
15 Key Finding in The Global Vinorelbine Tartrate API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(api)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る